|
Originally published In Press as doi:10.1074/jbc.M105160200 on August 10, 2001
J. Biol. Chem., Vol. 276, Issue 41, 38108-38114, October 12, 2001
Mutation of Trp1254 in the Multispecific Organic
Anion Transporter, Multidrug Resistance Protein 2 (MRP2)
(ABCC2), Alters Substrate Specificity and Results in Loss of
Methotrexate Transport Activity*
Ken-ichi
Ito §¶,
Curtis J.
Oleschuk § **,
Chris
Westlake ,
Monika Z.
Vasa ,
Roger G.
Deeley , and
Susan
P. C.
Cole  
From the Cancer Research Laboratories and the
Department of Pharmacology & Toxicology, Queen's University,
Kingston, Ontario K7L 3N6, Canada
The ATP-binding cassette (ABC)
proteins comprise a large superfamily of transmembrane transporters
that utilize the energy of ATP hydrolysis to translocate their
substrates across biological membranes. Multidrug resistance protein
(MRP) 2 (ABCC2) belongs to subfamily C of the ABC superfamily and, when
overexpressed in tumor cells, confers resistance to a wide variety of
anticancer chemotherapeutic agents. MRP2 is also an active transporter
of organic anions such as methotrexate (MTX), estradiol glucuronide (E217 G), and leukotriene C4 and is
located on the apical membrane of polarized cells including hepatocytes
where it acts as a biliary transporter. We recently identified a highly
conserved tryptophan residue in the related MRP1 that is critical for
the substrate specificity of this protein. In the present study, we
have examined the effect of replacing the analogous tryptophan residue
at position 1254 of MRP2. We found that only nonconservative
substitutions (Ala and Cys) of Trp1254 eliminated
[3H]E217 G transport by MRP2, whereas more
conservative substitutions (Phe and Tyr) had no effect. In addition,
only the most conservatively substituted mutant (W1254Y) transported
[3H]leukotriene C4, whereas all other
substitutions eliminated transport of this substrate. On the other
hand, all substitutions of Trp1254 eliminated transport of
[3H]MTX. Finally, we found that sulfinpyrazone stimulated
[3H]E217 G transport by wild-type MRP2
4-fold, whereas transport by the Trp1254 substituted
mutants was enhanced 6-10-fold. In contrast, sulfinpyrazone failed to
stimulate [3H]MTX transport by either wild-type MRP2 or
the MRP2-Trp1254 mutants. Taken together, our results
demonstrate that Trp1254 plays an important role in the
ability of MRP2 to transport conjugated organic anions and identify
this amino acid in the putative last transmembrane segment (TM17) of
this ABC protein as being critical for transport of MTX.
*
This work was supported by Grant MOP-10519 from the Canadian
Institutes for Health Research.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These two authors contributed equally to this work.
¶
Present address: Dept. of Surgery (II), Shinshu University
School of Medicine, 3-1-1 Asahi, Matsumoto Nagamo 390-8621, Japan.
**
Recipient of a Medical Research Council of Canada/Canadian
Institutes for Health Research Doctoral Award and an Ontario Graduate Scholarship.

Senior Scientist of Cancer Care Ontario. To whom correspondence
should be addressed: Cancer Research Laboratories, Rm. 328, Botterell
Hall, Queen's University, Kingston, ON K7L 3N6, Canada. Tel.:
613-533-2636; Fax: 613-533-6830; E-mail: coles@post.queensu.ca.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. A. K. El-Sheikh, J. J. M. W. van den Heuvel, E. Krieger, F. G. M. Russel, and J. B. Koenderink
Functional Role of Arginine 375 in Transmembrane Helix 6 of Multidrug Resistance Protein 4 (MRP4/ABCC4)
Mol. Pharmacol.,
October 1, 2008;
74(4):
964 - 971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Bandler, C. J. Westlake, C. E. Grant, S. P. C. Cole, and R. G. Deeley
Identification of Regions Required for Apical Membrane Localization of Human Multidrug Resistance Protein 2
Mol. Pharmacol.,
July 1, 2008;
74(1):
9 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zimmermann, K. van de Wetering, E. van de Steeg, E. Wagenaar, C. Vens, and A. H. Schinkel
Species-Dependent Transport and Modulation Properties of Human and Mouse Multidrug Resistance Protein 2 (MRP2/Mrp2, ABCC2/Abcc2)
Drug Metab. Dispos.,
April 1, 2008;
36(4):
631 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Letourneau, A. J. Slot, R. G. Deeley, and S. P. C. Cole
Mutational Analysis of a Highly Conserved Proline Residue in MRP1, MRP2, and MRP3 Reveals a Partially Conserved Function
Drug Metab. Dispos.,
August 1, 2007;
35(8):
1372 - 1379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Gerk, W. Li, V. Megaraj, and M. Vore
Human Multidrug Resistance Protein 2 Transports the Therapeutic Bile Salt Tauroursodeoxycholate
J. Pharmacol. Exp. Ther.,
February 1, 2007;
320(2):
893 - 899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Choudhuri and C. D. Klaassen
Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters
International Journal of Toxicology,
July 1, 2006;
25(4):
231 - 259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Deeley, C. Westlake, and S. P. C. Cole
Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins.
Physiol Rev,
July 1, 2006;
86(3):
849 - 899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Westlake, S. P.C. Cole, and R. G. Deeley
Role of the NH2-terminal Membrane Spanning Domain of Multidrug Resistance Protein 1/ABCC1 in Protein Processing and Trafficking
Mol. Biol. Cell,
May 1, 2005;
16(5):
2483 - 2492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Moreau, F. Gally, H. Jacquet-Bouix, and M. Vivaudou
The Size of a Single Residue of the Sulfonylurea Receptor Dictates the Effectiveness of KATP Channel Openers
Mol. Pharmacol.,
April 1, 2005;
67(4):
1026 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Wolf, T Stranzl, M Filipits, G Pohl, R Pirker, B Leeb, and J S Smolen
Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis
Ann Rheum Dis,
April 1, 2005;
64(4):
564 - 568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ninomiya, K. Ito, and T. Horie
FUNCTIONAL ANALYSIS OF DOG MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2) IN COMPARISON WITH RAT MRP2
Drug Metab. Dispos.,
February 1, 2005;
33(2):
225 - 232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. M. H. Van Aubel, P. H. E. Smeets, J. J. M. W. van den Heuvel, and F. G. M. Russel
Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites
Am J Physiol Renal Physiol,
February 1, 2005;
288(2):
F327 - F333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Westlake, L. Payen, M. Gao, S. P. C. Cole, and R. G. Deeley
Identification and Characterization of Functionally Important Elements in the Multidrug Resistance Protein 1 COOH-terminal Region
J. Biol. Chem.,
December 17, 2004;
279(51):
53571 - 53583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hambrock, T. Kayar, D. Stumpp, and H. Osswald
Effect of Two Amino Acids in TM17 of Sulfonylurea Receptor SUR1 on the Binding of ATP-Sensitive K+ Channel Modulators
Diabetes,
December 1, 2004;
53(suppl_3):
S128 - S134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Gerk, W. Li, and M. Vore
ESTRADIOL 3-GLUCURONIDE IS TRANSPORTED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 BUT DOES NOT ACTIVATE THE ALLOSTERIC SITE BOUND BY ESTRADIOL 17-GLUCURONIDE
Drug Metab. Dispos.,
October 1, 2004;
32(10):
1139 - 1145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Leslie, A. Haimeur, and M. P. Waalkes
Arsenic Transport by the Human Multidrug Resistance Protein 1 (MRP1/ABCC1): EVIDENCE THAT A TRI-GLUTATHIONE CONJUGATE IS REQUIRED
J. Biol. Chem.,
July 30, 2004;
279(31):
32700 - 32708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Daidoji, H. Inoue, S. Kato, and H. Yokota
GLUCURONIDATION AND EXCRETION OF NONYLPHENOL IN PERFUSED RAT LIVER
Drug Metab. Dispos.,
August 1, 2003;
31(8):
993 - 998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Lockhart, R. G. Tirona, and R. B. Kim
Pharmacogenetics of ATP-binding Cassette Transporters in Cancer and Chemotherapy
Mol. Cancer Ther.,
July 1, 2003;
2(7):
685 - 698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bodo, E. Bakos, F. Szeri, A. Varadi, and B. Sarkadi
Differential Modulation of the Human Liver Conjugate Transporters MRP2 and MRP3 by Bile Acids and Organic Anions
J. Biol. Chem.,
June 20, 2003;
278(26):
23529 - 23537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Zelcer, M. T. Huisman, G. Reid, P. Wielinga, P. Breedveld, A. Kuil, P. Knipscheer, J. H. M. Schellens, A. H. Schinkel, and P. Borst
Evidence for Two Interacting Ligand Binding Sites in Human Multidrug Resistance Protein 2 (ATP Binding Cassette C2)
J. Biol. Chem.,
June 20, 2003;
278(26):
23538 - 23544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Konno, T. Ebihara, K. Hisaeda, T. Uchiumi, T. Nakamura, T. Shirakusa, M. Kuwano, and M. Wada
Identification of Domains Participating in the Substrate Specificity and Subcellular Localization of the Multidrug Resistance Proteins MRP1 and MRP2
J. Biol. Chem.,
June 13, 2003;
278(25):
22908 - 22917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Oleschuk, R. G. Deeley, and S. P. C. Cole
Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3
Am J Physiol Gastrointest Liver Physiol,
February 1, 2003;
284(2):
G280 - G289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Keitel, A. T. Nies, M. Brom, J. Hummel-Eisenbeiss, H. Spring, and D. Keppler
A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2)
Am J Physiol Gastrointest Liver Physiol,
January 1, 2003;
284(1):
G165 - G174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Koike, C. J. Oleschuk, A. Haimeur, S. L. Olsen, R. G. Deeley, and S. P. C. Cole
Multiple Membrane-associated Tryptophan Residues Contribute to the Transport Activity and Substrate Specificity of the Human Multidrug Resistance Protein, MRP1
J. Biol. Chem.,
December 13, 2002;
277(51):
49495 - 49503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Haidar, M. Denis, L. Krimbou, M. Marcil, and J. Genest Jr.
cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts
J. Lipid Res.,
December 1, 2002;
43(12):
2087 - 2094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Haimeur, R. G. Deeley, and S. P. C. Cole
Charged Amino Acids in the Sixth Transmembrane Helix of Multidrug Resistance Protein 1 (MRP1/ABCC1) Are Critical Determinants of Transport Activity
J. Biol. Chem.,
October 25, 2002;
277(44):
41326 - 41333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Mao, W. Qiu, K. E. Weigl, P. A. Lander, L. B. Tabas, R. L. Shepard, A. H. Dantzig, R. G. Deeley, and S. P. C. Cole
GSH-dependent Photolabeling of Multidrug Resistance Protein MRP1 (ABCC1) by [125I]LY475776. EVIDENCE OF A MAJOR BINDING SITE IN THE COOH-PROXIMAL MEMBRANE SPANNING DOMAIN
J. Biol. Chem.,
August 2, 2002;
277(32):
28690 - 28699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Gerk and M. Vore
Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition
J. Pharmacol. Exp. Ther.,
August 1, 2002;
302(2):
407 - 415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-W. Zhang, S. P. C. Cole, and R. G. Deeley
Determinants of the Substrate Specificity of Multidrug Resistance Protein 1. ROLE OF AMINO ACID RESIDUES WITH HYDROGEN BONDING POTENTIAL IN PREDICTED TRANSMEMBRANE HELIX 17
J. Biol. Chem.,
May 31, 2002;
277(23):
20934 - 20941.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|